These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1532407)

  • 21. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immune response to hepatitis B vaccine produced with genetic engineering].
    Ramón Torrell JM; Micheo Salas C; Cerdó Goicouria C; Casas García I; Escribá Jordana JM
    Rev Clin Esp; 1991 Feb; 188(2):68-71. PubMed ID: 2041902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can seroconversion rates to hepatitis vaccine among healthy subjects be improved?
    Barnass S; Davies SN; Bentley AH
    Lancet; 1986 Dec; 2(8519):1339. PubMed ID: 2878210
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant hepatitis B vaccine.
    Med Lett Drugs Ther; 1986 Dec; 28(728):118-9. PubMed ID: 2946924
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
    JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection?
    Luo KX; Wang LP; Nie J; Jiang S
    J Infect Dis; 1992 Apr; 165(4):777-8. PubMed ID: 1532408
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccine.
    Capiau C
    Dev Biol Stand; 1998; 96():127-9. PubMed ID: 9890526
    [No Abstract]   [Full Text] [Related]  

  • 32. Age-related response to hepatitis B vaccine in the mentally retarded.
    Torre D; Maggiolo F; Broggini M; Botta V
    Lancet; 1984 Oct; 2(8407):866. PubMed ID: 6148591
    [No Abstract]   [Full Text] [Related]  

  • 33. [Reactivity and immunogenicity of Engerix B, the recombinant DNA vaccine against hepatitis B].
    Borcić B; Gasparović V; Mihaljevic I; Aleraj B; Margan IG
    Acta Med Iugosl; 1989; 43(4):247-54. PubMed ID: 2534021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Pasteur hepatitis B vaccine in medical students.
    Hengster P; Kofler H; Eigentler A; Larcher C; Petzer A; Schulz T; Fritsch P; Dierich MP
    Lancet; 1986 Dec; 2(8519):1339-40. PubMed ID: 2878211
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B vaccines--to switch or not to switch.
    Hollinger FB
    JAMA; 1987 May; 257(19):2634-6. PubMed ID: 2952813
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant therapy for non-responders to reduced doses of hepatitis B vaccine during infancy.
    Arya SC
    Vaccine; 1991 Aug; 9(8):604. PubMed ID: 1837647
    [No Abstract]   [Full Text] [Related]  

  • 37. [Induction of HBs antibodies using a new genetically engineered vaccine].
    Just M; Berger R; Wegmann A; Glück R
    Schweiz Rundsch Med Prax; 1988 Dec; 77(51):1407-9. PubMed ID: 2975822
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
    Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
    JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serologic response to a DNA recombinant vaccine against hepatitis B in natives of the Peruvian Amazonian jungle].
    Colichón A; Vildósola H; Sjogren M; Cantella R; Rojas C
    Rev Gastroenterol Peru; 1990; 10(2):71-4. PubMed ID: 2151848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
    Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
    J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.